Silicon Valley Capital Partners »

Regeneron Pharmaceuticals shares owned by Silicon Valley Capital Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Silicon Valley Capital Partners from 13F filings

Historical chart of Silicon Valley Capital Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Silicon Valley Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Silicon Valley Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3k 4 564.75
2025-06-30 $2.1k 4 526.50
2025-03-31 $2.6k 4 638.25
2024-12-31 $2.8k 4 712.25

More positions owned by Silicon Valley Capital Partners

Spdr S&p 500 Etf Trust Etf (SPY)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard Information Technology Etf Etf (VGT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Microsoft Corp Stock (MSFT)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Amazon Stock (AMZN)
Meta Platforms Inc Cl A Stock (META)
Ishares S&p 500 Growth Etf Etf (IVW)
Broadcom Stock (AVGO)
Oracle Corp Stock (ORCL)
Servicenow Stock (NOW)

View all positions for Silicon Valley Capital Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals